Deutsche Bank raised the firm’s price target on Hims & Hers to $43 from $38 and keeps a Hold rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS:
- Hims & Hers Health, Inc. Reports Strong Q1 Earnings
- Is Hims & Hers Health Stock (HIMS) the Target of a Meme-Driven Short Squeeze?
- Hims & Hers rises 13.6%
- Hims & Hers could see profit taking on ‘mixed’ report, says Morgan Stanley
- Hims & Hers Health: Strong Financial Performance and Strategic Initiatives Drive Buy Rating